A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease

Ken Ogasawara1, Shinichi Mashiba, Youichiro Wada

  • 1The Cardiovascular Institute, Roppongi 7-3-10 Minato-ku, Tokyo 106-0032, Japan. ij3k-ogsw@asahi-net.or.jp

Atherosclerosis
|May 12, 2004
PubMed

Insights

The SAA/LDL complex, a novel inflammatory marker, shows greater sensitivity than CRP or SAA in predicting prognosis for patients with stable coronary artery disease (CAD). This finding offers a new tool for risk stratification in cardiovascular disease management.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Inflammation Research

Background:

  • Prognostic value of acute phase proteins like CRP and SAA in acute coronary syndrome is known.
  • The predictive capability of these inflammatory markers in stable coronary artery disease (CAD) remains unclear.
  • This study aimed to clarify the prognostic significance of inflammatory markers in stable CAD patients.

Purpose of the Study:

  • To evaluate the prognostic value of serum amyloid A/low-density lipoprotein (SAA/LDL) complex in patients with stable coronary artery disease (CAD).
  • To compare the predictive power of SAA/LDL complex against established markers like C-reactive protein (CRP) and serum amyloid A (SAA).

Main Methods:

  • Prospective cohort study of 140 patients with stable CAD.
  • Measurement of serum SAA/LDL complex using sandwich ELISA, alongside CRP and SAA levels.
  • Defined endpoints included cardiac death, myocardial infarction, cerebral infarction, and coronary revascularization.

Main Results:

  • 21 endpoint events occurred during the study period.
  • Independent predictors of adverse events included age, diabetes mellitus, triglyceride levels, and SAA/LDL complex concentration.
  • SAA/LDL complex (per 10 microg/ml) showed an odds ratio of 2.32 (CI: 1.05-4.70) for event occurrence.
  • Reconstitution experiments indicated SAA/LDL complex formation via oxidative interaction between SAA and lipoproteins.

Conclusions:

  • The SAA/LDL complex directly reflects intravascular inflammation.
  • SAA/LDL complex serves as a novel, sensitive marker for predicting prognosis in stable CAD patients.
  • This marker demonstrates superior predictive capability compared to CRP or SAA in this patient population.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...